I think the 3.1m was a sell but the 2.8m was an off book buy at the end. Some quite big positions being unwound / taken. Amazed we've not had a TR-1 already this week.
gkb- exactly. An SI print (which is what the 1m was marked as) will be a bank matching large orders internally. I often find that large orders done on systematic internalisers are insti flow, so will be interesting to see if we have a new buyer (and also who sold).
Thing is BUTD it's not like you've been a little bit wrong with this share, you've been several hundred percent wrong. Coming back with the same arguments on a down day isn't going to change that..
I'm sure he probably will once June if out the way. We're kind of in a bit of a no mans land at the moment but in the space of 3 weeks we'll know the status of the government grant and have had an EGM. That should draw a line under things and the company can move forward and discuss contracts rather than funding.
I think the reason it's attracting a lot of new money is because they aren't tied into a specific drug development, they are kind of selling shovels to the gold miners as it were. Yes it can still be a flop but at least it's not all dependent on the next clinical trial
This has totally died. I guess nobody willing to buy significantly whilst the threat of a placing is there, but nobody selling as there could be a decent contract announced soon.
Do you mean net short as in there have been too many buyers and they've sold more than they own .. or are you asking if they have a naked short position on the stock?
Another collaboration we haven't heard much about since it signed.. they have recently released a report saying there's a new focus from companies on 5g and cloud following the impact of covid-
Interesting headline in The Telegraph today, "The Prime Minister has instructed officials to draw up plans that would see China’s involvement in the UK's 5G network reduced to zero. Not sure which British company they would replace Huawei with?! Probably good news for tech from Israel I'd have thought..
I'm on Twitter.. in fact I'm one of the few that post on the ETX tag. It just doesn't seem to get the same traffic as some of the other biotechs. I think it's because the daily rises aren't in the 100's of percent and you actually have to be patient to make money. I bought my shares here last August but a lot of the ramp accounts on twitter can't do that as they have to be constantly jumping about into different shares to impress their followers.
Can trace that 14,940 sell back to mid March. Fair enough they made a couple of pence profit.. My biased view is that we may contract news in the next couple of weeks and then news on the Israeli grant. In 6 weeks time it could all look a lot different here - hopefully for the better!